Dr. Ashkan Emadi outlines eligibility, referral and care logistics for a first-in-world subcutaneous Blincyto trial at WVU Cancer Institute.
Dr. Ashkan Emadi
Advertisement
Dr. Ashkan Emadi is chair of the Department of Medical Oncology; Alexander Bland Osborn Endowed Chair and distinguished professor of Medical Oncology; physician-in-chief of Medical Oncology; and associate director for Clinical Research at WVU Cancer Institute.
Articles by Dr. Ashkan Emadi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
4
If I Have Cancer Again
5